A cancer charity has said it is "angry and frustrated" that ministers and health officials have not approved the provision of ...

Investigators found that some patients with high-risk nonmetastatic hormone-sensitive prostate cancer were understaged by ...

Community leaders are coming together to support colorectal and prostate cancer awareness with a little friendly competition.

Erectile dysfunction is common after prostate cancer treatment. A new study shows that aerobic exercise and strength training ...

While prostate cancer statistics may seem daunting, advances in detection, treatment, and active surveillance offer patients ...

Prostate cancer affects one in eight men during their lifetime, making it the second most common cancer among American males.

New research from Edith Cowan University (ECU) has confirmed that erectile dysfunction in patients living with prostate ...

After surgical removal of the prostate to treat prostate cancer, clinicians monitor prostate specific antigen (PSA) levels.

Lu rhPSMA-10.1 showed high tumor radiation with low healthy tissue exposure in a phase 1/2 trial for metastatic ...

Dr. Chandler Park sat down for an interview with CURE® to discuss the biggest takeaway from the 2025 ASCO GU Symposium in ...

Scott Eggener, MD, gave a talk at the LUGPA annual meeting titled “Leveraging Cutting-Edge Technologies to Enhance Prostate Cancer Treatments.” ...

Investigators assess the impact of increasing persistent PSA levels on prostate cancer–specific mortality and all-cause ...